Page last updated: 2024-09-02

gr 127935 and Migraine Disorders

gr 127935 has been researched along with Migraine Disorders in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gommeren, W; Haegeman, G; Heylen, L; Lesage, AS; Leysen, JE; Luyten, WH; Schotte, A; Van de Weyer, I; Van Gompel, P; Vanhoenacker, P; Wouters, R1
Blanchet, JC; John, GW; Le Grand, B; Létienne, R; Sole, E1
Goadsby, PJ; Hoskin, KL1
De Vries, P; Heiligers, JP; Saxena, PR; Villalón, CM; Willems, EW1
De Vries, P; Heiligers, JP; Saxena, PR; Trion, M; Villalón, CM; Willems, EW1

Other Studies

5 other study(ies) available for gr 127935 and Migraine Disorders

ArticleYear
Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamin
    Molecular pharmacology, 1996, Volume: 50, Issue:6

    Topics: Animals; Benzopyrans; Cattle; Cloning, Molecular; Glioma; HeLa Cells; Humans; Mice; Migraine Disorders; Propylamines; Protein Binding; Pyrimidines; Radioligand Assay; Receptors, Serotonin; Serotonin Receptor Agonists; Signal Transduction; Tritium; Tumor Cells, Cultured; Vasoconstrictor Agents

1996
Donitriptan decreases jugular venous oxygen saturation in rats in the absence of cranial vasoconstriction: an overlooked mechanism of antimigraine action?
    The Journal of pharmacology and experimental therapeutics, 2005, Volume: 315, Issue:2

    Topics: Animals; Blood Gas Analysis; Cerebrovascular Circulation; Hemodynamics; Jugular Veins; Male; Migraine Disorders; Nitriles; Oxadiazoles; Oxygen; Piperazines; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Serotonin Antagonists; Serotonin Receptor Agonists; Sumatriptan; Tryptamines; Vasoconstriction

2005
Serotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5HT1B/1D receptor: a central action in migraine?
    Annals of neurology, 1998, Volume: 43, Issue:6

    Topics: Animals; Cats; Electric Stimulation; Electrophysiology; Membrane Potentials; Migraine Disorders; Neural Inhibition; Oxadiazoles; Piperazines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Trigeminal Nucleus, Spinal

1998
The antimigraine agent alniditan selectively constricts porcine carotid arteriovenous anastomoses via 5-HT1B/1D receptors.
    European journal of pharmacology, 1998, Jun-19, Volume: 351, Issue:2

    Topics: Analgesics; Animals; Arteriovenous Anastomosis; Benzopyrans; Carotid Arteries; Hemodynamics; Humans; Jugular Veins; Male; Migraine Disorders; Oxadiazoles; Oxygen; Piperazines; Propylamines; Pyrimidines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Swine; Vasoconstrictor Agents

1998
Pharmacological evidence that alpha1-and alpha2-adrenoceptors mediate vasoconstriction of carotid arteriovenous anastomoses in anaesthetized pigs.
    British journal of pharmacology, 1999, Volume: 127, Issue:5

    Topics: Anesthesia; Animals; Arteriovenous Anastomosis; Azepines; Carotid Arteries; Hemodynamics; Migraine Disorders; Oxadiazoles; Phenylephrine; Piperazines; Prazosin; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Receptors, Serotonin; Sumatriptan; Swine; Vasoconstriction

1999